• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995年至2014年中国成年人2型糖尿病患病率的长期趋势:一项荟萃分析。

Secular trends in the prevalence of type 2 diabetes in adults in China from 1995 to 2014: A meta-analysis.

作者信息

Han Chengyi, Zhang Ming, Luo Xinping, Wang Chongjian, Yin Lei, Pang Chao, Feng Tianping, Ren Yongcheng, Wang Bingyuan, Zhang Lu, Li Linlin, Yang Xiangyu, Zhang Hongyan, Zhao Yang, Zhou Junmei, Xie Zhihui, Zhao Jingzhi, Hu Dongsheng

机构信息

Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, China.

Department of Prevention and Health Care, The Affiliated Luohu Hospital of Shenzhen University Health Sciences Center, Shenzhen, China.

出版信息

J Diabetes. 2017 May;9(5):450-461. doi: 10.1111/1753-0407.12440. Epub 2016 Aug 22.

DOI:10.1111/1753-0407.12440
PMID:27282985
Abstract

BACKGROUND

The aim of the present study was to estimate trends in the prevalence of type 2 diabetes mellitus (T2DM) in adults in China.

METHODS

A systematic search was conducted for studies of T2DM prevalence in adults in China from 2000 to 2014. Pooled prevalence was calculated by a random-effects model. Subgroup and sensitivity analyses were performed. Chi-squared and Cochran-Mantel-Haenszel tests were used to assess differences among subgroups and pooled prevalence, respectively.

RESULTS

Forty-six studies (data from 1995 to 2014; 1 463 079 adults) were included in the meta-analysis. The overall prevalence of T2DM was 7.9 %. The pooled prevalence overall and by location (urban and rural), gender (male and female), and age category (18-39, 40-59, and ≥60 years) was 4.5 %, 5.1 % and 3.0 %, 4.0 % and 4.2 %, and 1.4 %, 5.0 %, and 10.3 %, respectively, from 1995 to 1999; 6.6 %, 9.3 % and 5.6 %, 7.4 % and 7.5 %, and 1.8 %, 5.9 %, and 12.4 %, respectively, from 2000 to 2004; 10.3 %, 11.8 % and 6.8 %, 10.0 % and 8.6 %, and 2.8 %, 10.3 %, and 20.0 %, respectively, from 2005 to 2009; and 8.3 %, 12.5 % and 7.6 %, 8.6 % and 8.0 %, and 3.5 %, 8.5 %, and 15.3 %, respectively, from 2010 to 2014. The prevalence increased from 5.8 % to 11.6 % with per-capita gross domestic product and differed by diagnostic criteria.

CONCLUSIONS

There was a trend of increasing prevalence of T2DM in adults in China from 1995 to 2009, with a decrease in 2010-14 and a greater increase over time in urban versus rural areas, males versus females, and older versus younger adults.

摘要

背景

本研究旨在评估中国成年人2型糖尿病(T2DM)患病率的变化趋势。

方法

对2000年至2014年中国成年人T2DM患病率的研究进行系统检索。采用随机效应模型计算合并患病率。进行亚组分析和敏感性分析。分别使用卡方检验和 Cochr an-Mantel-Haenszel检验评估亚组间差异和合并患病率。

结果

46项研究(数据来自1995年至2014年;1463079名成年人)纳入荟萃分析。T2DM的总体患病率为7.9%。1995年至1999年,总体合并患病率以及按地区(城市和农村)、性别(男性和女性)和年龄组(18 - 39岁、40 - 59岁和≥60岁)划分的患病率分别为4.5%、5.1%和3.0%,4.0%和4.2%,以及1.4%、5.0%和10.3%;2000年至2004年分别为6.6%、9.3%和5.6%,7.4%和7.5%,以及1.8%、5.9%和12.4%;2005年至2009年分别为10.3%、11.8%和6.8%,10.0%和8.6%,以及2.8%、10.3%和20.0%;2010年至2014年分别为8.3%、12.5%和7.6%,8.6%和8.0%,以及3.5%、8.5%和15.3%。患病率随人均国内生产总值从5.8%增至11.6%,且因诊断标准而异。

结论

1995年至2009年中国成年人T2DM患病率呈上升趋势,2010 - 2014年有所下降,且城市与农村、男性与女性、老年人与年轻人相比,随时间推移患病率上升幅度更大。

相似文献

1
Secular trends in the prevalence of type 2 diabetes in adults in China from 1995 to 2014: A meta-analysis.1995年至2014年中国成年人2型糖尿病患病率的长期趋势:一项荟萃分析。
J Diabetes. 2017 May;9(5):450-461. doi: 10.1111/1753-0407.12440. Epub 2016 Aug 22.
2
Diabetes and obesity trends in Fiji over 30 years.斐济30年来的糖尿病和肥胖趋势。
J Diabetes. 2016 Jul;8(4):533-43. doi: 10.1111/1753-0407.12326. Epub 2015 Sep 15.
3
National trend in congenital heart disease mortality in China during 2003 to 2010: a population-based study.中国 2003 至 2010 年先天性心脏病死亡率的全国趋势:一项基于人群的研究。
J Thorac Cardiovasc Surg. 2014 Aug;148(2):596-602.e1. doi: 10.1016/j.jtcvs.2013.08.067. Epub 2013 Oct 24.
4
Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study.中国农村人群 2 型糖尿病及其危险因素、知晓率、治疗率和控制率:农村糖尿病研究。
Sci Rep. 2016 Aug 11;6:31426. doi: 10.1038/srep31426.
5
Trends in overweight and obesity in Chinese adults: between 1991 and 1999-2000.中国成年人超重和肥胖的趋势:1991年至1999 - 2000年
Obesity (Silver Spring). 2008 Jun;16(6):1448-53. doi: 10.1038/oby.2008.208. Epub 2008 Apr 3.
6
[The secular trend of prevalence and risk factors for type 2 diabetes mellitus in the rural Henan population].[河南农村人群2型糖尿病患病率及危险因素的长期趋势]
Wei Sheng Yan Jiu. 2010 May;39(3):306-9.
7
Increasing incidence and prevalence with limited survival gains among rural Albertans with diabetes: a retrospective cohort study, 1995-2006.在阿尔伯塔省农村地区,糖尿病的发病率和患病率不断上升,但生存获益有限:1995-2006 年回顾性队列研究。
Diabet Med. 2009 Oct;26(10):989-95. doi: 10.1111/j.1464-5491.2009.02805.x.
8
Prevalence of type 2 diabetes mellitus among inland residents in China (2000-2014): A meta-analysis.中国内陆居民 2 型糖尿病患病率(2000-2014 年)的荟萃分析。
J Diabetes Investig. 2016 Nov;7(6):845-852. doi: 10.1111/jdi.12514. Epub 2016 Apr 27.
9
Prevalence of Type 2 diabetes in urban and rural Chinese populations in Qingdao, China.中国青岛城乡人群2型糖尿病患病率
Diabet Med. 2005 Oct;22(10):1427-33. doi: 10.1111/j.1464-5491.2005.01658.x.
10
Prevalence of passive smoking in the community population aged 15 years and older in China: a systematic review and meta-analysis.中国15岁及以上社区人群被动吸烟患病率:一项系统评价与Meta分析
BMJ Open. 2016 Apr 8;6(4):e009847. doi: 10.1136/bmjopen-2015-009847.

引用本文的文献

1
Trends of diabetes in Beijing, China.中国北京的糖尿病趋势。
Chin Med J (Engl). 2025 Mar 20;138(6):713-720. doi: 10.1097/CM9.0000000000003207. Epub 2024 Jul 8.
2
Changes in the prevalence of diabetes and control of risk factors for diabetes among Chinese adults from 2007 to 2017: An analysis of repeated national cross-sectional surveys.2007 年至 2017 年中国成年人糖尿病患病率和糖尿病危险因素控制的变化:基于多次全国横断面调查的分析。
J Diabetes. 2024 Feb;16(2):e13492. doi: 10.1111/1753-0407.13492. Epub 2023 Nov 5.
3
Gender Differences Between the Phenotype of Short Stature and the Risk of Diabetes Mellitus in Chinese Adults: A Population-Based Cohort Study.
性别差异与中国成年人矮小表型和糖尿病风险之间的关系:一项基于人群的队列研究。
Front Endocrinol (Lausanne). 2022 Apr 5;13:869225. doi: 10.3389/fendo.2022.869225. eCollection 2022.
4
Transition of cardiometabolic status and the risk of type 2 diabetes mellitus among middle-aged and older Chinese: A national cohort study.中国中老年人群中心血管代谢状态的转变与 2 型糖尿病发病风险:一项全国性队列研究。
J Diabetes Investig. 2022 Aug;13(8):1426-1437. doi: 10.1111/jdi.13805. Epub 2022 May 5.
5
Evaluation of the Association between Obesity Markers and Type 2 Diabetes: A Cohort Study Based on a Physical Examination Population.肥胖标志物与 2 型糖尿病相关性的评估:基于体检人群的队列研究。
J Diabetes Res. 2021 Dec 28;2021:6503339. doi: 10.1155/2021/6503339. eCollection 2021.
6
Association of serum 25-hydroxyvitamin D with metabolic syndrome and type 2 diabetes: a one sample Mendelian randomization study.血清 25-羟维生素 D 与代谢综合征和 2 型糖尿病的关联:一项单样本 Mendelian 随机研究。
BMC Geriatr. 2021 Jun 29;21(1):391. doi: 10.1186/s12877-021-02307-6.
7
Transition of Hypertriglyceridemic-Waist Phenotypes and the Risk of Type 2 Diabetes Mellitus among Middle-Aged and Older Chinese: A National Cohort Study.中国中老年人群中心性肥胖伴高三酰甘油血症表型的转变与 2 型糖尿病发病风险的关系:一项全国性队列研究。
Int J Environ Res Public Health. 2021 Apr 1;18(7):3664. doi: 10.3390/ijerph18073664.
8
Gender differences of relationship between serum lipid indices and type 2 diabetes mellitus: a cross-sectional survey in Chinese elderly adults.血清脂质指标与2型糖尿病关系的性别差异:一项针对中国老年人的横断面调查
Ann Transl Med. 2021 Jan;9(2):115. doi: 10.21037/atm-20-2478.
9
Inhibition of SNCG suppresses the proliferation of lung cancer cells induced by high glucose.抑制SNCG可抑制高糖诱导的肺癌细胞增殖。
Mol Med Rep. 2021 Feb;23(2). doi: 10.3892/mmr.2020.11777. Epub 2020 Dec 14.
10
Triglyceride is an independent predictor of type 2 diabetes among middle-aged and older adults: a prospective study with 8-year follow-ups in two cohorts.甘油三酯是中老年人群 2 型糖尿病的独立预测因子:两项队列 8 年前瞻性研究
J Transl Med. 2019 Dec 3;17(1):403. doi: 10.1186/s12967-019-02156-3.